Health100 is designed as a cross-stakeholder digital destination, avoiding closed proprietary architectures to connect ...
Pharma Pulse: Antengene–UCB $1.18 Billion License Agreement and AI-Driven Value Chain Efficiencies
In today’s Pharma Pulse, Antengene and UCB ink a $1.18 billion global deal for ATG-201 to target autoimmune diseases, while ...
Esperion Therapeutics has entered into a definitive agreement to acquire Corstasis Therapeutics, a privately held biopharmaceutical company. The acquisition focuses on the integration of Enbumystâ„¢ ...
The FDA has transitioned to a "new era" of proactive enforcement, issuing warning letters to telehealth and pharmaceutical ...
Eton Pharmaceuticals. Eton Pharmaceuticals expands rare disease portfolio through acquisition of U.S. commercialization ...
In today's Pharma Pulse, the FDA expands the pediatric indication for Juxtapid to treat rare homozygous familial ...
SpotSee and Controlant announced a collaboration to enhance pharmaceutical supply chain visibility using integrated ...
Thermal testing can make or break cold chain performance. Join this webinar to learn proven best practices that help eliminate blind spots, validate designs, and protect temperature-sensitive ...
In today’s Pharma Pulse, the FDA grants priority review to a therapy for polycythemia vera, while Novo Nordisk receives ...
A conversation with Kenco’s Tim McClatchy explores how pharmaceutical logistics providers are strengthening cybersecurity ...
The Inflation Reduction Act (IRA) of 2022 introduced sweeping changes to the US prescription drug market, most notably ...
Global life sciences supply chain conference LogiPharma has announced a brand-new series of interactive formats for 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results